Polar Capital Holdings »

Halozyme Therapeutics shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2022-12-31 $2.4M 2.5M 0.97

More positions owned by Polar Capital Holdings

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Arch Cap Group Ord (ACGL)
Amazon (AMZN)
Renaissance Re Holdings Ltd Cmn (RNR)
Chubb (CB)
Servicenow (NOW)
Marsh & McLennan Companies (MMC)
Crowdstrike Hldgs Cl A (CRWD)
Hubspot (HUBS)

View all positions for Polar Capital Holdings

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics